Long Term Follow Up of A Phase II Trial of High Dose Radiation with Concurrent 5-Fluorouracil and Cisplatin in Patients with Anal Cancer (ECOG E4292)

PURPOSE: Although chemoradiation using 5-fluorouracil (5-FU) and Mitomycin-C (MMC) is the standard of care in the treatment of anal cancer, many patients are unable to tolerate MMC. This phase II clinical trial was performed to determine if cisplatin could replace MMC in the treatment of anal cancer...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chakravarthy, A Bapsi, Catalano, Paul J., Martenson, James. A., Mondschein, Joshua K., Wagner, Henry, Mansour, Edward G., Talamonti, Mark S., Benson, Al Bowen
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3197794/
https://ncbi.nlm.nih.gov/pubmed/21514072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2011.02.042
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados